Johnson Investment Counsel’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-7,880
Closed -$258K 571
2014
Q3
$258K Sell
7,880
-73,370
-90% -$2.25M 0.01% 478
2014
Q2
$2.47M Sell
81,250
-37,550
-32% -$1.17M 0.09% 125
2014
Q1
$3.46M Buy
118,800
+4,710
+4% +$126K 0.13% 102
2013
Q4
$2.98M Buy
114,090
+70,500
+162% +$1.81M 0.11% 115
2013
Q3
$1.17M Buy
+43,590
New +$1.17M 0.05% 175

Other funds holding MED

Johnson Investment Counsel's MED Position: Q4 2014 in Review

Johnson Investment Counsel sold out of Medifast (MED) in Q4 2014, closing a stake of 7,880 shares — an estimated $258K sold.

Johnson Investment Counsel first reported a position in MED in Q3 2013 and held it in 5 quarters. The position peaked at $3.46M in Q1 2014. 124 funds tracked by Wall St. Rank hold MED as of Q4 2014.

  • Johnson Investment Counsel reported no remaining Medifast position as of Q4 2014 after selling out during the quarter.
  • Johnson Investment Counsel sold 7,880 Medifast shares in Q4 2014, an estimated $258K.
  • Johnson Investment Counsel first reported a position in Medifast in Q3 2013 and held it in 5 quarters.
  • Johnson Investment Counsel's Medifast position peaked at $3.46M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q4 2014.

Based on Johnson Investment Counsel's 13F filing for Q4 2014, filed 17 Feb 2015.